Molecular Analysis of Plasma from Patients with ROS1-Positive Non-Small Cell Lung Cancer by Dagogo-Jack, Ibiayi, Rooney, Marguerite, Nagy, Rebecca J., Lin, Jessica J., Chin, Emily, Ferris, Lorin A., Ackil, Jennifer, Lennerz, Jochen K., Lanman, Richard B., Gainor, Justin F., Shaw, Alice T.

Get full text

Brief Report: Increased Hepatotoxicity Associated with Sequential Immune Checkpoint Inhibitor and Crizotinib Therapy in Patients with Non-Small-Cell Lung Cancer by Lin, Jessica J., Chin, Emily, Yeap, Beow Y., Ferris, Lorin A., Kamesan, Vashine, Lennes, Inga T., Sequist, Lecia V., Heist, Rebecca S., Mino-Kenudson, Mari, Gainor, Justin F., Shaw, Alice T.

Get full text

ORAL02.03: Robust Correlation Between Metabolic Response Measured with 18F-FDG PET Soon After Therapy and Clinical Outcome in Lung Cancer: Topic: Radiation Oncology by Choi, Noah C., Gainor, Justin, Ackman, Jeanne, Lim, Ruth, Sharp, Gregory C., El Fakhri, Georges, Niemierko, Andrzej

Get full text

Three-year overall survival outcomes and correlative analyses in patients with non–small-cell lung cancer and high (50-89%) versus very high (≥90%) PD-L1 expression treated with fi... by Ricciuti, Biagio, Elkrief, Arielle, Lin, Jessica, Zhang, Jianjun, Alessi, Joao V., Lamberti, Giuseppe, Gandhi, Malini, Di Federico, Alessandro, Pecci, Federica, Wang, Xinan, Makarem, Maisam, Hidalgo Filho, Cassio Murilo, Gorria, Teresa, Pabon, Cindy, Lindsay, James, Pfaff, Kathleen L., Welsh, Emma L., Nishino, Mizuki, Sholl, Lynette M., Rodig, Scott, Kilickap, Saadettin, Rietschel, Petra, McIntyre, Debra AG, Pouliot, Jean-Francois, Altan, Mehmet, Gainor, Justin F., Heymach, John V., Schoenfeld, Adam J., Awad, Mark M.

Get full text

Brief Report: Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients with RET-Rearranged Lung Cancers by Drilon, Alexander, Lin, Jessica J., Filleron, Thomas, Ni, Ai, Milia, Julie, Bergagnini, Isabella, Hatzoglou, Vaios, Velcheti, Vamsidhar, Offin, Michael, Li, Bob, Carbone, David P., Besse, Benjamin, Mok, Tony, Awad, Mark M., Wolf, Jurgen, Owen, Dwight, Camidge, D. Ross, Riely, Gregory J., Peled, Nir, Kris, Mark G., Mazieres, Julien, Gainor, Justin F., Gautschi, Oliver

Get full text

Brigatinib in Patients with Alectinib-Refractory ALK-Positive Non-Small Cell Lung Cancer: A Retrospective Study by Lin, Jessica J., Zhu, Viola W., Schoenfeld, Adam J., Yeap, Beow Y., Saxena, Ashish, Ferris, Lorin A., Dagogo-Jack, Ibiayi, Farago, Anna F., Taber, Angela, Traynor, Anne, Menon, Smitha, Gainor, Justin F., Lennerz, Jochen K., Plodkowski, Andrew J., Digumarthy, Subba R., Ou, Sai-Hong Ignatius, Shaw, Alice T., Riely, Gregory J.

Get full text

Alectinib Dose Escalation Re-induces Central Nervous System Responses in ALK-Positive Non-Small Cell Lung Cancer (NSCLC) Patients Relapsing on Standard Dose Alectinib by Gainor, Justin F., Chi, Andrew S., Logan, Jennifer, Hu, Ranliang, Oh, Kevin S., Brastianos, Priscilla K., Shih, Helen A., Shaw, Alice T.

Get full text

P2.06-019 A Phase II Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Patients (pts) with Resectable Non-Small Cell Lung Cancer (NSCLC): Topic: Phase II + NK by Owen, Dwight, Bunn, Paul, Johnson, Bruce, Kwiatkowski, David, Kris, Mark, Wistuba, Ignacio, Gandhi, Mayank, Phan, See, Shames, David, Schulze, Katja, Bernaards, Coen, Aisner, Dara, Chaft, Jamie, Gainor, Justin, Lee, Jay, Minna, John, Mino-Kenudson, Mari, Garcia-Prieto, Celia, Rusch, Valerie, Sabichi, Anita, Villaruz, Liza, Wozniak, Antoinette, Carbone, David

Get full text

P2.06-019 A Phase II Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Patients (pts) with Resectable Non-Small Cell Lung Cancer (NSCLC) by Owen, Dwight, Bunn, Paul, Johnson, Bruce, Kwiatkowski, David, Kris, Mark, Wistuba, Ignacio, Gandhi, Mayank, Phan, See, Shames, David, Schulze, Katja, Bernaards, Coen, Aisner, Dara, Chaft, Jamie, Gainor, Justin, Lee, Jay, Minna, John, Mino-Kenudson, Mari, Garcia-Prieto, Celia, Rusch, Valerie, Sabichi, Anita, Villaruz, Liza, Wozniak, Antoinette, Carbone, David

Get full text

PF-06463922, an ALK/ROS1 inhibitor, overcomes resistance to 1st and 2nd generation ALK inhibitors in pre-clinical models by Zou, Helen Y., Friboulet, Luc, Kodack, David P., Engstrom, Lars D., Li, Qiuhua, West, Melissa, Tang, Ruth W., Wang, Hui, Tsaparikos, Konstantinos, Wang, Jinwei, Timofeevski, Sergei, Katayama, Ryohei, Dinh, Dac M., Lam, Hieu, Lam, Justine L., Yamazaki, Shinji, Hu, Wenyue, Patel, Bhushankumar, Bezwada, Divya, Frias, Rosa L., Lifshits, Eugene, Mahmood, Sidra, Gainor, Justin F., Affolter, Timothy, Lappin, Patrick B., Gukasyan, Hovhannes, Lee, Nathan, Deng, Shibing, Jain, Rakesh K, Johnson, Ted W., Shaw, Alice T., Fantin, Valeria R., Smeal, Tod

Get full text

Association between immune-related adverse events and clinical outcomes to PD-1/PD-L1 blockade in small cell lung cancer by Ricciuti, Biagio, Naqash, Abdul Rafeh, Naidoo, Jarushka, Sehgal, Kartik, Miller, Adam, Kehl, Kenneth, Venkatraman, Deepti, Sands, Jacob, Lamberti, Giuseppe, Recondo, Gonzalo, Zhang, Jiajia, Macherla, Shravanti, Baig, Sameer, Walker, Paul, Rangachari, Deepa, Gainor, Justin F., Costa, Daniel B., Rizvi, Naiyer, Sholl, Lynette M., Nishino, Mizuki, Henick, Brian, Farago, Anna F., Awad, Mark M.

Get full text

ORAL02.03: Robust Correlation Between Metabolic Response Measured with 18 F-FDG PET Soon After Therapy and Clinical Outcome in Lung Cancer: Topic: Radiation Oncology by Choi, Noah C, Gainor, Justin, Ackman, Jeanne, Lim, Ruth, Sharp, Gregory C, El Fakhri, Georges, Niemierko, Andrzej

Get full text

Thrombin-Dependent Platelet Activation Is VWF-Independent during Thrombus Formation In Vivo by Dubois, Christophe, Panicot-Dubois, Laurence, Gainor, Justin F., Furie, Barbara C., Furie, Bruce

Get full text

Brief Report: Declining Rates of SARS-CoV-2 Vaccine Uptake Among Patients With Thoracic Malignancies by Meador, Catherine B, Naranbhai, Vivek, Hambelton, Grace, Rivera, Julia, Nabel, Christopher S, Lewinsohn, Rebecca, Sakhi, Mustafa, Balazs, Alejandro B, Iafrate, A John, Gainor, Justin F

Get full text

Intracranial Activity of Gefitinib and Capmatinib in a Patient with Previously Treated Non-Small Cell Lung Cancer Harboring a Concurrent EGFR Mutation and MET Amplification by Gainor, Justin F, Stevens, Sara E, Willers, Henning, Shih, Helen A, Heist, Rebecca S

Get full text

Emergence of a RET V804M Gatekeeper Mutation During Treatment With Vandetanib in RET-Rearranged NSCLC by Dagogo-Jack, Ibiayi, Stevens, Sara E, Lin, Jessica J, Nagy, Rebecca, Ferris, Lorin, Shaw, Alice T, Gainor, Justin F

Get full text